Results 231 to 240 of about 439,656 (359)
Association between various dosage forms of semaglutide and ocular adverse events in a real-world setting. [PDF]
Zhao T +5 more
europepmc +1 more source
Development and Validation of HPTLC Method for the Simultaneous Estimation of Amlodipine Besylate and Atorvastatin Calcium in Combined Dosage Form [PDF]
Nagasarapu Mallıkarjuna Rao +1 more
openalex
We investigated the toxicity of 12 active compounds commonly found in herbal weight loss supplements (WLS) using human liver and colon cell models. Epigallocatechin‐3‐gallate was the only compound showing significant toxicity. Metabolic profiling revealed protein degradation, disrupted energy and lipid metabolism suggesting that the inclusion of EGCG ...
Emily C. Davies +3 more
wiley +1 more source
Feasibility of Hot Melt Extrusion in Converting Water-Based Nanosuspensions into Solid Dosage Forms. [PDF]
Ragucci E +6 more
europepmc +1 more source
CRISPRI‐mediated gene silencing and phenotypic exploration in nontuberculous mycobacteria. In this Research Protocol, we describe approaches to control, monitor, and quantitatively assess CRISPRI‐mediated gene silencing in M. smegmatis and M. abscessus model organisms.
Vanessa Point +7 more
wiley +1 more source
Oral dosage forms for drug delivery to the colon: an existing gap between research and commercial applications. [PDF]
Martínez E +7 more
europepmc +1 more source
Aged human bmMSCs are seeded in the scaffold. Osteoblastic induction can slightly increase cell's bone‐forming activity to produce bone‐like tissues, shown as the sporadic xylenol orange‐stained spots (the lower left image). Notably, pioglitazone plus EGCG co‐treatment dramatically increases cell's bone‐forming activity and bone‐like tissue production (
Ching‐Yun Chen +6 more
wiley +1 more source
A survey of regulatory recommendations for waivers of <i>in vivo</i> bioequivalence studies of generic products for certain dosage forms by participating regulators and organisations of the International Pharmaceutical Regulators Programme. Part 2. [PDF]
García-Arieta A +37 more
europepmc +1 more source

